Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation

Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation

Aims: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been developed to treat non-small cell lung cancer (NSCLC) patients with EGFR mutation, but TKI resistance is common. Almost half of the acquired resistance patients are due to additional T790M mutation on EGFR (EGF...

Full description

Bibliographic Details
Main Authors:	Leung, Elaine Lai-Han, Fan, Xing-Xing, Wong, Maria Pik, Jiang, Zhi-Hong, Liu, Zhong-Qiu, Yao, Xiao-Jun, Lu, Lin-Lin, Zhou, Yan-Ling, Yau, Li-Fong, Tin, Vicky Pui-Chi, Liu, Liang
Format:	Online
Language:	English
Published:	Mary Ann Liebert, Inc. 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753639/

Similar Items

Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
by: Liao, Bin-Chi, et al.
Published: (2016)

Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma
by: Wang Yuli, et al.
Published: (2016-01-01)

Concomitant T790M mutation and small‐cell lung cancer transformation after acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor
by: Fujita, Kohei, et al.
Published: (2016)

Overcoming EGFR T790M-based Tyrosine Kinase Inhibitor Resistance with an Allele-specific DNAzyme
by: Lai, Wei-Yun, et al.
Published: (2014)

Methionine Partially Replaced by Methionyl-Methionine Dipeptide Improves Reproductive Performance over Methionine Alone in Methionine-Deficient Mice
by: Qiong Chen, et al.
Published: (2018-09-01)

Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation
by: Hanan, Emily J., et al.
Published: (2014)

Structure-Functional Study of Tyrosine and Methionine Dipeptides: An Approach to Antioxidant Activity Prediction
by: Torkova, Anna, et al.
Published: (2015)

Small Cell Transformation and T790M Mutation as Coresistance Mechanisms for First-line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy Failure
by: Chee, Shee-Chai
Published: (2017)

The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis
by: Ding, Ding, et al.
Published: (2014)

Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital
by: Venkata Pradeep Babu Koyyala, et al.
Published: (2018-01-01)

Impaired degradation followed by enhanced recycling of epidermal growth factor receptor caused by hypo-phosphorylation of tyrosine 1045 in RBE cells
by: Gui, Anping, et al.
Published: (2012)

Formyl-methionine as a degradation signal at the N-termini of bacterial proteins
by: Piatkov, Konstantin I., et al.
Published: (2015)

The Epidermal Growth Factor Receptor (EGFR / HER-1) Gatekeeper Mutation T790M Is Present in European Patients with Early Breast Cancer
by: Bemanian, Vahid, et al.
Published: (2015)

Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report
by: WANG, YUE FENG, et al.
Published: (2014)

Transtinib, a potent tyrosine kinase inhibitor inhibits L858R/T790M mutant NSCLC cell lines and xenografts
by: Hu, Peng, et al.
Published: (2016)

Radiotherapy for asymptomatic brain metastasis in epidermal growth factor receptor mutant non-small cell lung cancer without prior tyrosine kinase inhibitors treatment: a retrospective clinical study
by: Liu, SongRan, et al.
Published: (2015)

EGFR T790M detection and osimertinib treatment response evaluation by liquid biopsy in lung adenocarcinoma patients with acquired resistance to first generation EGFR tyrosine kinase inhibitors
by: Chenguang Li, et al.
Published: (2018-08-01)

Characterization of methionine oxidation and methionine sulfoxide reduction using methionine-rich cysteine-free proteins
by: Liang, Xinwen, et al.
Published: (2012)

Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
by: Wang, Shuhang, et al.
Published: (2016)

In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features
by: Xiang, Mingli, et al.
Published: (2013)

Serum lipid levels are positively correlated with lumbar disc herniation—a retrospective study of 790 Chinese patients
by: Zhang, Yuedong, et al.
Published: (2016)

Structural dynamics of a methionine γ-lyase for calicheamicin biosynthesis: Rotation of the conserved tyrosine stacking with pyridoxal phosphate
by: Cao, Hongnan, et al.
Published: (2016)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
by: Chang, Shih-Chieh, et al.
Published: (2011)

Current understanding of tyrosine kinase BMX in inflammation and its inhibitors
by: Qiu, Le, et al.
Published: (2014)

Clonostachys rosea demethiolase STR3 controls the conversion of methionine into methanethiol
by: Jia, Kai-Zhi, et al.
Published: (2016)

EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation
by: Yamada, Teppei, et al.
Published: (2013)

The DAF-16/FOXO Transcription Factor Functions as a Regulator of Epidermal Innate Immunity
by: Zou, Cheng-Gang, et al.
Published: (2013)

Pathology of Bursae of Fabricius in Methionine-Deficient Broiler Chickens
by: Wu, Bangyuan, et al.
Published: (2013)

Spindle orientation and epidermal morphogenesis
by: Kulukian, Anita, et al.
Published: (2013)

Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis
by: Liu, Li-na, et al.
Published: (2013)

Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer
by: Li, Hongde, et al.
Published: (2016)

EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer
by: Wang, Shuhang, et al.
Published: (2016)

THE ROLE OF l-METHIONINE IN VIRUS PROPAGATION
by: Ackermann, W. W.
Published: (1951)

Bacterial variations on the methionine salvage pathway
by: Sekowska, Agnieszka, et al.
Published: (2004)

The methionine salvage pathway in Bacillus subtilis
by: Sekowska, Agnieszka, et al.
Published: (2002)

Role of Methionine Adenosyltransferase Genes in Hepatocarcinogenesis
by: Ramani, Komal, et al.
Published: (2011)

Propionylcarnitine and methionine concentrations in newborns with hypospadias
by: Kowal, Andrzej, et al.
Published: (2013)

The epidermal growth factor receptor regulates cofilin activity and promotes transmissible gastroenteritis virus entry into intestinal epithelial cells
by: Hu, Weiwei, et al.
Published: (2016)

Epidermal Barrier in Atopic Dermatitis
by: Kim, Byung Eui, et al.
Published: (2012)

Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
by: Chen, Yu-Mu, et al.
Published: (2015)